Literature DB >> 20102557

Assessing outcomes in liver disease patients: reliability and validity of the Spanish version of the Liver Disease Quality of Life Questionnaire (LDQOL 1.0).

Teresa Casanovas1, Laia Jané, Michael Herdman, Alfonso Casado, Beatriz Garcia, Bibiana Prat, Joan Fabregat.   

Abstract

OBJECTIVE: To assess the reliability and validity of a Spanish version of the LDQOL 1.0 (Liver Disease Quality of Life questionnaire).
METHODS: Observational, cross-sectional study in Spanish patients awaiting liver transplantation (LT). Feasibility was assessed by analyzing administration times and missing responses. Ceiling and floor effects were calculated and reliability was tested by examining internal consistency (Cronbach's alpha). Convergent validity was tested by examining correlations between LDQOL disease-specific and Short Form health survey with 36 questions (SF-36) dimensions. Known groups' validity was tested by examining the LDQOL's capacity to discriminate between groups defined by etiology and Child-Turcotte-Pugh (CTP) scores.
RESULTS: A total of 200 patients were included for analysis. Mean age (SD) was 52.6 (9.8) years and 73% of the sample were male. The most common indication for LT was liver cancer (34%). Mean (SD) time to complete the questionnaire was 35.8 minutes (21.2 minutes). Missing responses were highest on the dimensions of sexual functioning and symptoms of liver disease. Ceiling effects were over 20% on 7 of the LDQOL's 12 disease-specific scales. Cronbach's alpha coefficients were over 0.70 on all but 2 dimensions. Correlations between SF-36 and LDQOL disease-specific dimensions generally fulfilled the hypotheses, with 35 of the 40 highest and lowest correlations (87.5%) being in the expected direction. The LDQOL discriminated well between patients in CTP class A and C, and as hypothesized, hepatocarcinoma and alcoholic cirrhosis patients scored better on most dimensions than patients with hepatitis C virus or other etiologies.
CONCLUSIONS: The Spanish version of the LDQOL 1.0 has shown satisfactory reliability and validity.

Entities:  

Mesh:

Year:  2010        PMID: 20102557     DOI: 10.1111/j.1524-4733.2009.00688.x

Source DB:  PubMed          Journal:  Value Health        ISSN: 1098-3015            Impact factor:   5.725


  5 in total

Review 1.  Measuring symptoms in gastrointestinal cancer: a systematic review of assessment instruments.

Authors:  Rachelle Pullmer; Wolfgang Linden; Katerina Rnic; Andrea Vodermaier
Journal:  Support Care Cancer       Date:  2014-05-28       Impact factor: 3.603

2.  Comparing the performance of the standard EQ-5D 3L with the new version EQ-5D 5L in patients with chronic hepatic diseases.

Authors:  Luciana Scalone; Roberta Ciampichini; Stefano Fagiuoli; Ivan Gardini; Francesco Fusco; Laura Gaeta; Anna Del Prete; Giancarlo Cesana; Lorenzo G Mantovani
Journal:  Qual Life Res       Date:  2012-11-29       Impact factor: 4.147

3.  Assessment of nutritional status and health-related quality of life before and after liver transplantation.

Authors:  María Teresa García-Rodríguez; María Del Carmen Piñón-Villar; Beatriz López-Calviño; Alejandra Otero-Ferreiro; Francisco Suárez-López; Manuel Gómez-Gutiérrez; Salvador Pita-Fernández
Journal:  BMC Gastroenterol       Date:  2015-01-22       Impact factor: 3.067

4.  The Association between Vitamin D Insufficiency and Nonalcoholic Fatty Liver Disease: A Population-Based Study.

Authors:  Yeonjung Ha; Seong Gyu Hwang; Kyu Sung Rim
Journal:  Nutrients       Date:  2017-07-27       Impact factor: 5.717

5.  Health-related quality of life in primary hepatic cancer: a systematic review assessing the methodological properties of instruments and a meta-analysis comparing treatment strategies.

Authors:  Kerstin Wohlleber; Patrick Heger; Pascal Probst; Christoph Engel; Markus K Diener; André L Mihaljevic
Journal:  Qual Life Res       Date:  2021-07-20       Impact factor: 4.147

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.